New findings shed light on complexities of emerging zoonotic malaria
2015-05-28
Zoonotic malaria has been shown to be caused by two genetically distinct Plasmodium knowlesi parasite subpopulations associated with different monkey host species in Malaysia, according to new research published in PLOS Pathogens. The authors believe this could have important implications for how the parasite adapts and spreads in humans.
Plasmodium knowlesi is a zoonotic malaria parasite which is common in forest-dwelling macaques. In recent years, increasing numbers of cases of knowlesi malaria have been reported in humans. The disease is now the most common form of ...
Wild chimps teach Stanford scientists about gene that encodes HIV-fighting protein
2015-05-28
Different people can vary substantially in their genetic susceptibility to viruses, including HIV. Although the biology that underlies this variation in humans is still being uncovered, it seems that we may be able to learn some key lessons from our closest cousins. A gene variant in chimpanzees in a Tanzanian wildlife preserve probably protects them from rapidly succumbing to the primate equivalent of HIV, Stanford University School of Medicine scientists report in the open access journal PLOS Biology, publishing May 28.
The wild chimps inhabit Gombe Stream National ...
Unlearning implicit social biases during sleep
2015-05-28
EVANSTON, Ill. --- Can we learn to rid ourselves of our implicit biases regarding race and gender? A new Northwestern University study indicates that sleep may hold an important key to success in such efforts.
Building on prior research, the Northwestern investigators aimed to find out whether learning to alter habitual reactions to other people could be enhanced during sleep.
Other researchers have documented many unsavory consequences of common social biases. When playing a videogame with instructions to shoot only people carrying weapons, players were more likely ...
New study shows influence on climate of fresh water during last ice age
2015-05-28
CORVALLIS, Ore. - A new study shows how huge influxes of fresh water into the North Atlantic Ocean from icebergs calving off North America during the last ice age had an unexpected effect - they increased the production of methane in the tropical wetlands.
Usually increases in methane levels are linked to warming in the Northern Hemisphere, but scientists who are publishing their findings this week in the journal Science have identified rapid increases in methane during particularly cold intervals.
These findings are important, researchers say, because they identify ...
ASCO: MEDI4736 combined with tremelimumab results in acceptable toxicity in NSCLC patients
2015-05-28
TAMPA, Fla. - Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer. Scott J. Antonia, M.D., Ph.D., chair of the Thoracic Oncology Department at Moffitt Cancer Center will be presenting data from a phase 1b dose-escalation and expansion study of MEDI4736 combined with tremelimumab at the 2015 American Society of Clinical Oncology ...
ASCO: Component in green tea may help reduce prostate cancer in men at high risk
2015-05-28
TAMPA, Fla. - Prostate cancer is the second most common type of cancer in men and is predicted to result in an estimated 220,00 cases in the United States in 2015. In recent years, an emphasis has been placed on chemoprevention - the use of agents to prevent the development or progression of prostate cancer. A team of researchers led by Nagi B. Kumar, Ph.D., R.D., F.A.D.A. at Moffitt Cancer Center recently published results of a randomized trial that assessed the safety and effectiveness of the active components in green tea to prevent prostate cancer development in men ...
ASCO: JAK2 inhibitor ruxolitinib has promising efficacy in CMML patients
2015-05-28
TAMPA, Fla. - Chronic myelomonocytic leukemia (CMML) is a rare type of myelodysplastic, myeloproliferative neoplasm characterized by increased numbers of peripheral monocytes and less than 20 percent blasts. CMML has few treatment options and patients only survive on average for 12 to 24 months. Preclinical studies suggest that JAK2 inhibitors may be an effective treatment option for CMML. Eric Padron, M.D., assistant member of the Malignant Hematology Program at Moffitt Cancer Center will report on the first phase 1 study of the JAK2 inhibitor ruxolitinib in CMML patients ...
ASCO: Nivolumab treatment in melanoma patients has manageable safety profile
2015-05-28
TAMPA, Fla. - The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients. Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center will be presenting data from a retrospective analysis of the safety of nivolumab in 4 ongoing phase I-III studies in melanoma patients at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.
Nivolumab targets a protein called the programmed death-1 (PD-1) receptor. The ...
Understanding how cells follow electric fields
2015-05-28
Many living things can respond to electric fields, either moving or using them to detect prey or enemies. Weak electric fields may be important growth and development, and in wound healing: it's known that one of the signals that guides cells into a wound to repair it is a disturbance in the normal electric field between tissues. This ability to move in response to an electric field is called galvanotaxis or electrotaxis.
UC Davis dermatology professor Min Zhao, Peter Devroetes at Johns Hopkins University and colleagues hope to unravel how these responses work, studying ...
Nineteen medical school deans join together to call for sustainable biomedical research funding
2015-05-28
Unstable funding is threatening the viability of academic biomedical research in this country, according to a new paper published this week in the journal Science Translational Medicine. The paper was written jointly by the deans of 19 prominent medical schools around the country. Among this group is University of Maryland School of Medicine Dean E. Albert Reece.
"We must reinvigorate the federal-academic partnership for research across all sciences," the authors write. If the current trends in funding continue, both established investigators and early-career scientists ...
New rapid-deployment plasma protocol effectively treats trauma patients quicker in the ER
2015-05-28
CHICAGO (May 28, 2015): Traumatic injury is the leading cause of death among people under age 45, but if trauma physicians could deliver plasma to these injury victims within minutes of their arrival in the emergency room, more of them would stand a better chance of survival.
When they arrive at the hospital, trauma victims can often wait 30 minutes or longer to receive plasma because the traditional way of giving them plasma involves two time-consuming steps: testing for blood type and then thawing frozen plasma. "There's a golden hour after trauma where you need to ...
Vulnerability found in some drug-resistant bacteria
2015-05-28
Using a complex modeling program that helps analyze the physical dynamics of large, structurally complex protein molecules, a research team has made progress towards finding a weak spot in the architecture of a group of enzymes that are essential to antibiotic resistance in a number of bacteria.
In an article published in PLOS ONE, University of North Carolina at Charlotte senior biology major Jenna R. Brown and her faculty mentor, UNC Charlotte professor of bioinformatics and genomics Dennis R. Livesay, present an analysis of the four currently known protein structures ...
Scientists discover key to what causes immune cell migration to wounds
2015-05-28
Immune cells play an important role in the upkeep and repair of our bodies, helping us to defend against infection and disease. Until now, how these cells detect a wounded or damaged site has largely remained a mystery. New research, led by University of Bristol academics in collaboration with a team from the University of Sheffield, has identified the triggers which lead these cells to react and respond in cell repair.
It is hoped the findings, published in Current Biology, could help scientists design therapies to manipulate the cell repair process and direct immune ...
Do you have the time? Flies sure do
2015-05-28
Flies might be smarter than you think. According to research reported in the Cell Press journal Current Biology on May 28, fruit flies know what time of day it is. What's more, the insects can learn to connect different scents with the sweet reward of sugar, depending on the hour: menthol in the morning and mushrooms in the afternoon.
Researchers say that the findings show the surprising mental abilities of animals, no matter how small.
"If even the fly, with its miniature brain, has the sense of time, most animals may have it," says Martin Heisenberg of Rudolf Virchow ...
Controlling typhoid bacterium key to prevent gallbladder cancer in India and Pakistan
2015-05-28
Controlling bacterial infections responsible for typhoid fever could dramatically reduce the risk of gallbladder cancer in India and Pakistan, according to a study published by Cell Press May 28th in Cell Host & Microbe. The findings establish for the first time the causal link between bacterial infection and gallbladder cancer, explaining why this type of cancer is rare in the West but common in India and Pakistan, where typhoid fever is endemic. Public policy changes inspired by this research could have an immediate impact on preventing a type of cancer that currently ...
A new tool to study an important anti-cancer and immunosuppressive target
2015-05-28
The chemical rapamycin is used clinically as an immunosuppressant and as an anti-cancer agent that works by inactivating a protein named TOR (Target Of Rapamycin). This protein is essential for the growth of normal cells, but is hyperactive in tumor cells. To be able to carry out its various growth-related tasks, TOR needs to assemble into one of two larger protein complexes named TORC1 and TORC2. Curiously, whereas TORC1 is inhibited by rapamycin, TORC2 is unaffected by this drug. The team of Robbie Loewith, professor in biology at the University of Geneva (UNIGE), Switzerland, ...
Bladder cells regurgitate bacteria to prevent UTIs
2015-05-28
DURHAM, N.C. -- Duke Medicine researchers have found that bladder cells have a highly effective way to combat E. coli bacteria that cause urinary tract infections (UTIs).
In a study published online May 28, 2015, in the journal Cell, Duke researchers and their colleagues describe how bladder cells can physically eject the UTI-causing bacteria that manage to invade the host cell.
This response is analogous to having indigestion and vomiting to rid the stomach of harmful substances.
The finding suggests there may be a potential way to capitalize on this natural tendency ...
Out of Africa via Egypt
2015-05-28
New research suggests that European and Asian (Eurasian) peoples originated when early Africans moved north - through the region that is now Egypt - to expand into the rest of the world. The findings, published in the American Journal of Human Genetics, answer a long-standing question as to whether early humans emerged from Africa by a route via Egypt, or via Ethiopia.
The extensive public catalogue of the genetic diversity in Ethiopian and Egyptian populations developed for the project also now provides a valuable, freely available, reference panel for future medical ...
How we make emotional decisions
2015-05-28
CAMBRIDGE, MA -- Some decisions arouse far more anxiety than others. Among the most anxiety-provoking are those that involve options with both positive and negative elements, such choosing to take a higher-paying job in a city far from family and friends, versus choosing to stay put with less pay.
MIT researchers have now identified a neural circuit that appears to underlie decision-making in this type of situation, which is known as approach-avoidance conflict. The findings could help researchers to discover new ways to treat psychiatric disorders that feature impaired ...
Sanford-Burnham researchers identify a new target for treating drug-resistant melanoma
2015-05-28
La Jolla, Calif., May 28, 2015 - A new collaborative study led by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), published today in Cell Reports, provides new insight into the molecular changes that lead to resistance to a commonly prescribed group of drugs called BRAF inhibitors. The findings suggest that targeting newly discovered pathways could be an effective approach to improving the clinical outcome of patients with BRAF inhibitor-resistant melanoma tumors.
Melanoma is the deadliest form of skin cancer, killing more than 8,000 people ...
Sleep quality influences the cognitive performance of autistic and neurotypical children
2015-05-28
This news release is available in French.
One night of poor sleep significantly decreases performance on intelligence tests in children with autism spectrum disorder (ASD) and also in neurotypical children (without ASD). This is the conclusion made by researchers at the Hôpital Rivière-des-Prairies, affiliated with the Institut universitaire en santé mentale de Montréal and Université de Montréal.
For a paper published in the International Journal of Psychophysiology, the researchers observed the EEG measures of 13 autistic children ...
Health factors influence ex-prisoners' chances of returning to jail
2015-05-28
Ex-prisoners with a history of risky drug use, mental illness or poverty are more likely to end up back behind bars. Those who are obese, are chronically ill or have attempted suicide are more likely to remain in the community. These are some of the findings from an exploratory study into health-related factors that could be used to predict whether a person released from prison will end up in custody again. It was led by Emma Thomas of the University of Melbourne in Australia and is published in Springer's journal Health & Justice, an open access journal.
In many countries, ...
Public raises alarm about ineffectiveness of some Montagu's harrier conservation measures
2015-05-28
A citizen science programme reveals the protection measures for the Montagu's harrier in the cereal crop season in France to be ineffective if nests are not protected to decrease predation after harvesting. A study has been published as a result of this voluntary fieldwork, with the participation of the Hunting Resources Research Institute, which proposes fencing off the nests as a way of mitigating the damage and optimising conservation efforts in different areas.
Over the last decade there has been an explosion in the so-called citizen science programmes, in which people ...
In battle of the sexes, a single night with a New York male is enough to kill
2015-05-28
EUGENE, Ore. -- (May 28, 2015) -- Men and women often enter relationships with different long-term goals. In the animal world, differences in approaches to reproductive success can lead to sexual conflict.
Male fruit flies, for example, transfer proteins during mating that can alter the timing of a female's egg laying and her tendency to later mate with other males. Some of these male-derived proteins also migrate from the female's reproductive tract to her brain.
Now, in a new study, scientists of the University of Oregon and Bowdoin College show that sexual conflicts ...
Research roundup from Penn's Abramson Cancer Center
2015-05-28
CHICAGO -- Researchers from the Abramson Cancer Center of the University of Pennsylvania and Penn's Perelman School of Medicine will present results from several clinical trials and other key studies during the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting from May 29 through June 2.
Results of Phase II Trial Show Successful Antitumor Response Rate in Patients with Advanced BRCA-Related Ovarian Cancer
Olaparib, an experimental twice-daily oral cancer drug, produces significant antitumor responses in more than a third of patients with BRCA-related ...
[1] ... [2302]
[2303]
[2304]
[2305]
[2306]
[2307]
[2308]
[2309]
2310
[2311]
[2312]
[2313]
[2314]
[2315]
[2316]
[2317]
[2318]
... [8170]
Press-News.org - Free Press Release Distribution service.